Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 3 months ago
Share
Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
47 patients around the world
Available in
United States, Brazil
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1
Research sites
47
Patients around the world
This study is for people with
Prostate cancer
Castration resistant prostate cancer
Requirements for the patient
From 18 Years
Male
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Hospital Moinhos de Vento
View site
R. Ramiro Barcelos, 910 - Floresta, Porto Alegre - RS, 90035-001, Brazil
See details
Contact us
Contact us
Study
BAT-RAD
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study type
Interventional
Conditions
Castration resistant prostate cancer
Requirements
From 18 Years
Male
Unique study ID
clinicaltrials.gov
NCT04704505
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent